Effects of a mindfulness-based intervention and a health self-management programme on psychological well-being in older adults with subjective cognitive decline: Secondary analyses from the SCD-Well randomised clinical trial

PLoS One. 2023 Dec 15;18(12):e0295175. doi: 10.1371/journal.pone.0295175. eCollection 2023.

Abstract

Objectives: Older adults with subjective cognitive decline (SCD) recruited from memory clinics have an increased risk of developing dementia and regularly experience reduced psychological well-being related to memory concerns and fear of dementia. Research on improving well-being in SCD is limited and lacks non-pharmacological approaches. We investigated whether mindfulness-based and health education interventions can enhance well-being in SCD.

Methods: The SCD-Well trial (ClinicalTrials.gov: NCT03005652) randomised 147 older adults with SCD to an 8-week caring mindfulness-based approach for seniors (CMBAS) or an active comparator (health self-management programme [HSMP]). Well-being was assessed at baseline, post-intervention, and 6-month post-randomisation using the Psychological Well-being Scale (PWBS), the World Health Organisation's Quality of Life (QoL) Assessment psychological subscale, and composites capturing meditation-based well-being dimensions of awareness, connection, and insight. Mixed effects models were used to assess between- and within-group differences in change.

Results: CMBAS was superior to HSMP on changes in connection at post-intervention. Within both groups, PWBS total scores, psychological QoL, and composite scores did not increase. Exploratory analyses indicated increases in PWBS autonomy at post-intervention in both groups.

Conclusion: Two non-pharmacological interventions were associated with only limited effects on psychological well-being in SCD. Longer intervention studies with waitlist/retest control groups are needed to assess if our findings reflect intervention brevity and/or minimal base rate changes in well-being.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Cognitive Dysfunction* / therapy
  • Dementia*
  • Humans
  • Mindfulness* / methods
  • Psychological Well-Being
  • Quality of Life
  • Self-Management*

Associated data

  • ClinicalTrials.gov/NCT03005652

Grants and funding

The SCD-Well Randomised Controlled Trial is part of the Medit-Ageing project funded through the European Union in Horizon 2020 programme related to the call PHC22 “Promoting mental well-being in the ageing population” and under grant agreement No667696. FC was supported by Fonds National de la Recherche Scientifique (FRSFNRS, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.